186
18
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T37262 |
14,15-Leukotriene E4
14,15-Leukotriene E4 |
||
Leukotrienes (LTs) are a group of acute inflammatory mediators derived from arachidonic acid in leukocytes. The majority of these metabolites are formed through the 5-lipoxygenase (5-LO) pathway. 14,15-LTE4 is a metabolite of 14,15-LTC4 and 14,15-LTD4, an alternate class of LTs synthesized by a pathway involving the dual actions of 15- and 12-LOs on arachidonic acid via 15-HpETE and 14,15-LTA4 intermediates. These metabolites are classified as eoxins because they are formed mostly by eosinophils... | |||
T38128 |
Leukotriene D4
Leukotriene D4 MaxSpec® Standard,LTD4 |
||
Leukotriene D4 (LTD4) is one of the constituents of slow-reacting substance of anaphylaxis (SRS-A) produced by the metabolism of LTC4 by γ-glutamyl transpeptidase. It is the first cysteinyl-leukotriene metabolite of LTC4 . Like LTC4, LTD4-induced bronchoconstriction and enhanced vascular permeability contribute to the pathogenesis of asthma and acute hypersensitivity. LTD4 is equipotent to LTC4 in its biological activities, except that LTD4 is nearly 100-fold more effective in the contraction of... | |||
T37618 |
Leukotriene B4 dimethyl amide
Leukotriene B4 dimethyl amide |
||
LTB4 dimethyl amide is a moderate inhibitor of LTB4-induced degranulation of human neutrophils (Ki = 130 nM) and lysozyme release from rat PMNL. LTB4 dimethyl amide appears to be an antagonist of the LTB4 receptor on guinea pig lung membranes. | |||
T37493 |
11-trans Leukotriene D4
11-trans Leukotriene D4 |
||
11-trans Leukotriene D4 (11-trans LTD4) is a C-11 double bond isomer of LTD4. LTD4 undergoes slow temperature-dependent isomerization to 11-trans LTD4 during storage. 11-trans LTD4 retains about 10-25 % of the potency for contraction of guinea pig ileum, trachea and parenchyma compared to LTD4. It exhibits an ED50 ranging between 12-60 nM for contraction of guinea pig trachea. | |||
T38087 |
20-hydroxy Leukotriene B4
20-hydroxy Leukotriene B4 |
||
20-hydroxy LTB4 is a metabolite of LTB4 in human neutrophils. In human leukocytes, LTB4 is inactivated by the enzyme LTB4 20-hydroxylase. 20-hydroxy LTB4 is not only much less active (~5%) compared to LTB4 in causing degranulation of PMNL, but actually inhibits LTB4-induced degranulation of human neutrophils (Ki = 13.3 nM). However, 20-hydroxy LTB4 is as active as LTB4 in contracting parenchymal strips from guinea pig lung. 20-hydroxy LTB4 retains considerable ligand binding affinity at the BLT2... | |||
T37616 |
Leukotriene A4 methyl ester
Leukotriene A4 methyl ester |
||
白三烯A4甲酯可在大鼠肝脏中主要碱性胞质谷胱甘肽转移酶的催化下转化为白三烯C4单甲酯,可用于代谢相关研究。 | |||
T37492 |
11-trans Leukotriene C4
11-trans Leukotriene C4 |
||
11-trans Leukotriene C4 (11-trans LTC4) is a C-11 double bond isomer of LTC4. LTC4 undergoes slow temperature-dependent isomerization to 11-trans LTC4 during storage. 11-trans LTC4 is produced in smaller amounts relative to LTC4 in ionophore-stimulated HMC-1 cells (a human mast cell line) and equine eosinophils, but not in human neutrophils or RBL-1 cells. It is nearly equipotent with LTC4 for contraction of guinea pig parenchymal and ileum. In a radioligand binding assay using guinea pig ileum ... | |||
T37970 |
12-epi Leukotriene B4
12-epi Leukotriene B4 |
||
Leukotriene B4 (LTB4) compounds are produced by both enzymatic and non-enzymatic processes. The products of enzymatic origin, via Leukotriene A4 (LTA4) hydrolase, are stereospecifically 12(R). Non-enzymatic hydrolysis products are 50:50 mixtures at C-12, but are almost exclusively trans at C-6. Thus, the non-enzymatic hydrolysis product of LTA4 is 6-trans-12-epi LTB4. 12-epi LTB4 is an isomer which would not be expected to occur in either non-enzymatic hydrolysis products, or in the enzymatic pr... | |||
T37261 |
14,15-Leukotriene D4
14,15-Leukotriene D4 |
||
14,15-Leukotriene D4 (14,15-LTD4) is a member of an alternate class of LTs synthesized by a pathway involving the dual actions of 15- and 12-lipoxygenases (15- and 12-LOs) on arachidonic acid via 15-HpETE and 14,15-LTA4 intermediates. 14,15-LTD4 is classified as an eoxin (EXD4), because it is formed mostly by eosinophils. However, mast cells and nasal polyps can synthesize 14,15-LTD4 as well. Little is known about the physiological actions of 14,15-LTD4. It has weak contractile activity on both ... | |||
T37260 |
14,15-dehydro Leukotriene B4
14,15-dehydro Leukotriene B4 |
||
Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from arachidonic acid through the 5-lipoxygenase pathway. It promotes a number of leukocyte functions including aggregation, stimulation of ion fluxes, enhancement of lysosomal enzyme release, superoxide anion production, chemotaxis, and chemokinesis. At least two LTB4 receptors, termed BLT1 and BLT2, have been identified. 14,15-dehydro LTB4 is a LTB4 receptor antagonist that has a higher binding affinity for BLT1, demonstrating a Ki value ... | |||
T38062 |
N-acetyl Leukotriene E4
N-acetyl Leukotriene E4 |
||
N-acetyl LTE4 is the major inactive metabolite of LTE4 found in bile. This route of metabolism is prominent in the rat, but of minor importance in humans. N-acetyl LTE4 is 100 times less potent than LTC4 as a vasoconstricting agent. In healthy human subjects urinary excretion of N-acetyl LTE4 is about 1.5 nmol/mol creatinine, which is considerably less than that of LTE4 (12 nmol/mol creatinine). | |||
T37256 |
12-oxo Leukotriene B4
12-oxo Leukotriene B4 |
||
Leukotriene B4 (LTB4) is a dihydroxy fatty acid derived from arachidonic acid through the 5-LO pathway. It promotes a number of leukocyte functions including aggregation, stimulation of ion fluxes, enhancement of lysosomal enzyme release, superoxide anion production, chemotaxis, and chemokinesis. 12-oxo LTB4 is an initial metabolite of LTB4 formed via the LTB4 12-hydroxydehydrogenase pathway. It is rapidly converted to 10,11-dihydro-12-oxo-LTB4, followed by reduction of the 12-oxo group to give ... | |||
T37494 |
11-trans Leukotriene E4
11-trans Leukotriene E4 |
||
Slow isomerization of the C-11 double bond of LTE4 leads to the formation of 11-trans LTE4. 11-trans LTE4 is equipotent to LTE4 in contracting guinea pig ileum. | |||
T37980 |
N-methyl Leukotriene C4
N-methyl Leukotriene C4 |
||
Produced by neutrophils, macrophages, mast cells, and by transcellular metabolism in platelets, leukotriene C4 (LTC4) is the parent cysteinyl leukotriene formed by the LTC4 synthase-catalyzed conjugation of glutathione to LTA4. It is one of the constituents of slow-reacting substance of anaphylaxis (SRS-A) and exhibits potent smooth muscle contracting activity. LTC4, however, is rapidly metabolized to LTD4 and LTE4, which makes the characterization of LTC4 pharmacology difficult. N-methyl Leukot... | |||
T36423 |
Leukotriene B5
|
||
Leukotriene B5 (LTB5) is a leukotriene with diverse biological activities. It is a metabolite of eicosapentaenoic acid formed through the 5-lipoxygenase (5-LO) pathway. LTB5 increases contraction of bullfrog lung strips ex vivo in a concentration-dependent manner. In vivo, LTB5 (100 nM) reduces tumor volume in mice injected with Tm1 murine melanoma cells. LTB5 also elicits chemokinesis and lysosomal enzyme release from polymorphonuclear leukocytes (PMNLs) 20- to 30-fold less, and induces platele... | |||
T37617 |
Leukotriene B3
|
||
LTB3 is the LTA hydrolase metabolite of LTA3 in the leukotriene biosynthetic pathway. LTB3 and LTB4 are equipotent in their pro-inflammatory effects. However, LTB3 is five times less potent than LTB4 in eliciting chemotaxis of human neutrophils. | |||
T37619 |
Leukotriene B4 Ethanolamide
|
||
The effects of Leukotriene B4 (LTB4) are mediated by two known receptors, BLT1 and BLT2. LTB4 is a high affinity ligand for BLT1, and many of its pro-inflammatory effects are believed to be transduced through this receptor. The BLT2 is more enigmatic, in that LTB4 is not a high-affinity ligand, nor is it clear that BLT2 activation promotes inflammation. LTB4 ethanolamide (LTB4-EA) is a theoretical 5-LO metabolite of arachidonoyl ethanolamide (AEA). In CHO cells transfected with human BLTR1, LTB4... | |||
T38129 |
Leukotriene F4
LTF4 |
||
LTF4 is a cysteinyl-leukotriene produced in vitro, but not reported to date in vivo. It is formed by the incubation of LTE4 with γ-glutamyl transpeptidase and glutathione. LTF4 is a weak agonist in its ability to contract vascular smooth muscle. [1] The rank order of potency of the cysteinyl-leukotrienes to contract vascular smooth muscle is LTD4 > LTC4 > LTE4 >> LTF4. [1] [2] | |||
T40870 |
Leukotriene E4
LTE4 |
Endogenous Metabolite | Metabolism |
Leukotriene E4 (LTE4)(LTE4)通过 二肽酶对LTD4 上的作用生成,是过敏性休克慢反应物质(SRS-A)的成分之一。LTE4 存在于血浆和尿液中,可用于检测哮喘。 | |||
T37615 |
Leukotriene A3 methyl ester
|
||
Biosynthesis of LTA3 occurs from 5,8,11-eicosatrienoic acid via the 5-LO pathway and it is the putative intermediate in the biosynthesis of 3-series leukotrienes. LTA3 as a free acid is highly unstable. The methyl ester is stable and can be readily hydrolyzed to the free acid as needed. | |||
T14045 |
Leukotriene B4
LTB4,5(S),12(R)-DiHETE |
Others | Others |
Leukotriene B4 is an alkyl chain-based PROTAC linker that can be used in the synthesis of PROTACs[1]. | |||
T37620 |
Leukotriene C4 methyl ester
|
||
Leukotriene C4 (LTC4) is the parent cysteinyl-leukotriene produced by the LTC4 synthase-catalyzed conjugation of glutathione to LTA4. LTC4 is produced by neutrophils, macrophages, and mast cells, and by transcellular metabolism in platelets. It is one of the constituents of slow-reacting substance of anaphylaxis (SRS-A) and exhibits potent smooth muscle contracting activity. LTC4-induced bronchoconstriction and enhanced vascular permeability contribute to the pathogenesis of asthma and acute all... | |||
T32680 | Leukotriene E-4 sulfone | ||
Leukotriene E-4 sulfone is a synthetic leukotriene. | |||
T32681 |
Leukotriene F-4 sulfone
Ltf4 sulfone |
||
Leukotriene F-4 sulfone induces vascular permeability changes. | |||
T73793 |
20-Carboxy-Leukotriene B4
|
||
20-Carboxy-Leukotriene B4 (20-COOH LTB4) 是 Leukotriene B4 (LTB4) 的代谢物。20-Carboxy-Leukotriene B4 以高亲和力与 BLT1 受体结合。20-Carboxy-Leukotriene B4 抑制 LTB4 介导的中性粒细胞反应,迁移、脱粒、白三烯生物合成。 | |||
T1677L |
Montelukast sodium
MK0476,孟鲁司特钠 |
Leukotriene Receptor; LTR | GPCR/G Protein; Immunology/Inflammation |
Montelukast sodium (MK0476) 是可口服的半胱氨酸白三烯受体1 选择性拮抗剂,可用于研究预防哮喘和肝损伤。它还可减少心脏损伤,在肠缺血-再灌注损伤中也具有抗氧化作用。 | |||
T6893 |
MK-886
MK886,L 663536 |
Apoptosis; Leukotriene Receptor; COX; PPAR; FLAP | Apoptosis; DNA Damage/DNA Repair; GPCR/G Protein; Immunology/Inflammation; Metabolism; Neuroscience |
MK-886 (L 663536)是一种细胞可渗透的,具有口服活性的 FLAP (IC50为 30 nM) 和白三烯生物合成 (完整白细胞和人全血中的IC50分别为 3 nM 和 1.1μM) 的抑制剂。它也是一种非竞争性PPARα拮抗剂,可以诱导细胞凋亡。 | |||
T72144 |
6-trans-12-epi-Leukotriene B4
|
||
6-trans-12-epi-Leukotriene B4 是一种花生四烯酸代谢物,是一种有效的抗炎剂。 | |||
T22946 |
LY255283
LY 255283 |
Leukotriene Receptor | GPCR/G Protein |
LY255283 是白三烯 B4 (LTB4) 受体的特异性拮抗剂,抑制人外周血多形核白细胞和由钙离子载体 A23187 激活的单核细胞中 LTB(4) 的产生。 | |||
T0694 |
Pranlukast
普鲁司特,ONO-1078,普仑司特 |
Leukotriene Receptor; IL Receptor; Others; TNF; NF-κB; LTR | Apoptosis; GPCR/G Protein; Immunology/Inflammation; NF-κB; Others |
Pranlukast (ONO-1078) 是一种半胱氨酰白三烯受体 1 拮抗剂,可拮抗或减少支气管痉挛,用于哮喘研究。 | |||
T26519 |
Ablukast
Ro 23-3544,阿鲁司特 |
Leukotriene Receptor | GPCR/G Protein |
Ablukast (Ro 23-3544) 是白三烯受体的选择性拮抗剂,也是LTD4受体拮抗剂。可改善 LTC4 和抗原诱导的支气管狭窄。 | |||
T16280 |
Nedocromil
FPL 59002,尼多克罗 |
Leukotriene Receptor; Prostaglandin Receptor; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Nedocromil (FPL 59002) 对多种介质的作用或形成有抑制作用,包括组胺,前列腺素 D2和白三烯 C4。 | |||
T6736 |
Zafirlukast
Vanticon,ICI 204219,Accolate,扎鲁司特 |
Leukotriene Receptor | GPCR/G Protein |
Zafirlukast (ICI 204219) 是一种可口服的白三烯 D4受体拮抗剂,具有平喘、抗炎和抗菌作用。 | |||
T20615 |
Olsalazine
奥沙拉嗪,Dipentium,Salicylic acid |
Others | Others |
Olsalazine (Dipentium) 是一种抗炎药,用于治疗炎症性肠病。它也是一种新型的 DNA 去甲基化剂。 | |||
T22358 |
Etalocib
LY293111,VML295 |
Apoptosis; Leukotriene Receptor; LTR | Apoptosis; GPCR/G Protein; Immunology/Inflammation |
Etalocib (LY293111) 是一种具有口服活性的白三烯(LTB4)受体的拮抗剂,抑制 [3H]LTB4结合的 Ki 值为 25 nM。它还可诱导凋亡。它抑制 LTB4诱导的钙动员,lC50值为 20 nM。 | |||
T21696 |
SC-57461A
N -甲基- N -[3 - [4 - (苯甲基)苯氧基]丙基Β-丙氨酸盐酸盐 |
Aminopeptidase | Metabolism |
SC-57461A 是一种口服有活力的非肽类白三烯 A4 (LTA4) 水解酶选择性抑制剂,它能够抑制重组人 (IC50: 2.5 nM) 、小鼠 (IC50: 3 nM) 和小鼠LTA4水解酶 (IC50: 23 nM) 。 | |||
T1677 |
Montelukast
孟鲁司特,Singular |
Leukotriene Receptor; Lipoxygenase; LTR | GPCR/G Protein; Immunology/Inflammation; Metabolism |
Montelukast (Singular) 是可口服的半胱氨酸白三烯受体1 选择性拮抗剂,可用于研究预防哮喘和肝损伤。它还可减少心脏损伤,在肠缺血-再灌注损伤中也具有抗氧化作用。 | |||
T3148 |
MK-571 sodium
L-660711 (sodium salt),L-660711 sodium salt,Verlukast sodium,L-660711,MK571,MK-571 sodium salt,Propanoic acid |
Leukotriene Receptor; LTR | GPCR/G Protein; Immunology/Inflammation |
MK-571 sodium (L-660711 sodium salt) 是一种可口服的选择性白三烯 D4受体拮抗剂,在豚鼠和人肺膜的 Ki 分别为0.22 和 2.1 nM。 | |||
T22787 |
FPL 55712
|
Others | Others |
Leukotriene receptor antagonist | |||
T26524 |
ABT-080
VML530,VML-530,VML 530,ABT080 |
Leukotriene Receptor | GPCR/G Protein |
ABT-080 (VML 530)是白三烯合成的抑制剂,有用于治疗哮喘的潜力。 | |||
T24327 |
L 674573
L 674,573,L674,573,L-674,573,L674573,L-674573 |
Leukotriene Receptor | GPCR/G Protein |
L 674573是白三烯生物合成的抑制剂。 | |||
T15002 |
CP-105696
Pfizer 105696 |
LTR | Immunology/Inflammation |
CP-105696 是一种具有强效性和选择性白三烯 B4 (LTB4) 受体拮抗剂,可用于研究异体移植物排斥反应。 | |||
T10917 |
LTB4-IN-1
Anti-inflammatory agent 2 |
LTR | Immunology/Inflammation |
LTB4-IN-1 (Anti-inflammatory agent 2) 是白三烯 (LTB4) 合成抑制剂,IC50 为 70 nM。 | |||
T2583 |
Cilastatin
西司他丁,MK0791 |
Proteasome; Antibacterial; Antibiotic | Microbiology/Virology; Proteases/Proteasome; Ubiquitination |
Cilastatin (MK0791) 是一种可逆的竞争性的肾脏脱氢肽酶 I 抑制剂,IC50为 0.1 μM。它抑制细菌金属叶内酰胺酶CphA 的IC50为 178 μM,可用作抗菌辅助剂。 | |||
T27979 |
Masilukast
ICI-D-3523,ZD-3523,ICI D-3523,MCC-847,SA-09012,D-3523 |
Leukotriene Receptor | GPCR/G Protein |
Masilukast(MCC-847) 是一种口服的白三烯D4 (LTD4) 受体拮抗剂,可用于研究与炎症相关的疾病。 | |||
T28529 |
RG 7152
RG7152,RG-7152 |
Leukotriene Receptor | GPCR/G Protein |
RG 7152 是白三烯 D4 拮抗剂,具有抗哮喘作用,可作用于研究哮喘。 | |||
TQ0047 |
DG051
|
Aminopeptidase | Metabolism |
DG051 是有效的白三烯 A4 水解酶抑制剂,IC50=47 nM。 | |||
T12771 |
RS-601
|
Leukotriene Receptor; Thrombin | GPCR/G Protein; Proteases/Proteasome |
RS-601 是一种有效的 leukotriene D4/thromboxane A2 双重抑制剂,对抗原诱导的气道高反应性 (AHR)有抑制作用且在豚鼠哮喘模型中显示出平喘作用。 | |||
T16395 |
ONO4057
ONO-LB457 |
Leukotriene Receptor | GPCR/G Protein |
ONO4057 是一种具有有效性和口服活性的 Leukotriene B4 受体拮抗剂,其 IC50 值为 0.7±0.3 μM。 ONO4057 对大鼠同种异体移植的免疫抑制作用。 | |||
T15647 |
Tipelukast
MN 001,KCA 757 |
Leukotriene Receptor | GPCR/G Protein |
Tipelukast (KCA 757) 是一种新型可口服的白三烯受体 (leukotriene receptor) 拮抗剂,是具有抗炎活性,可减少纤维化,下调 TIMP-1、1 型胶原蛋白。Tipelukast 可用于研究哮喘疾病。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T25687 |
Leukotriene C4
白三烯C4,LTC4,Leukotriene C |
||
Leukotriene C4 is the conjugation product of Leukotriene A4 and glutathione. It is the major arachidonic acid metabolite in human mast cells, macrophages, and antigen-sensitized lung tissue. It stimulates mucus secretion in the lung and produces contracti | |||
T7786 |
Tryptanthrin
|
DNA gyrase | DNA Damage/DNA Repair |
Tryptanthrin 是一种口服具有活性的细胞内Leukotriene (LT) biosynthesis 抑制剂。 它能够降低大鼠胸膜炎模型中的 LTB4 水平,并抑制人全血中Leukotriene 的形成 (IC50= 10 µM)。 | |||
T5714 |
5-O-Demethylnobiletin
5-DEMETHYLNOBILETIN,去甲基川陈皮素 |
Leukotriene Receptor; Lipoxygenase | GPCR/G Protein; Metabolism |
5-O-Demethylnobiletin (5-DEMETHYLNOBILETIN) 是从黄芪中分离出的多甲氧基黄酮,具有抗炎活性,可通过直接抑制 5-LOX 发挥作用,IC50为 0.1 μM。 | |||
TN1182 |
11-Keto-beta-boswellic acid
11-Keto-beta-boswellic acid,11-酮基-BETA-乳香酸 |
Leukotriene Receptor; NF-κB; Lipoxygenase | GPCR/G Protein; Metabolism; NF-κB |
11-Keto-beta-boswellic acid 是来自乳香的一种五环三萜酸,具有抗炎活性和剂量依赖性心脏保护作用,主要是由于抑制5-脂氧合酶、白三烯、NF-κB 的激活和肿瘤坏死因子 α 的产生。 | |||
T21504 |
γ-Linolenic Acid methyl ester
Methyl gamma-linolenate,γ-亚麻酸甲酯 |
LTR | Immunology/Inflammation |
γ-Linolenic Acid methyl ester (Methyl gamma-linolenate) 是一种弱白三烯 B4 (LTB4) 受体拮抗剂。 | |||
T3529 |
Bestatin hydrochloride
盐酸乌苯美司,Ubenimex hydrochloride,苯丁抑制素 |
Integrin; Aminopeptidase; Antibacterial; Antibiotic | Cytoskeletal Signaling; Metabolism; Microbiology/Virology |
Bestatin hydrochloride (Ubenimex hydrochloride) 是CD13(Aminopeptidase N)/APN 和leukotriene A4 hydrolase 抑制剂,可研究癌症。 | |||
T4973 |
Paraxanthine
1,7-二甲基黄嘌呤,1,7-DIMETHYLXANTHINE |
Endogenous Metabolite | Metabolism |
Paraxanthine (1,7-dimethylxanthine) 是一种 caffeine 的代谢物,能够刺激Ryanodine 受体通道来抑制多巴胺能细胞的死亡。 | |||
T1257 |
Bestatin
Ubenimex,乌苯美司 |
Others; Aminopeptidase; Antibacterial; Antibiotic; LTR | Immunology/Inflammation; Metabolism; Microbiology/Virology; Others |
Bestatin (Ubenimex) 是 CD13 (Aminopeptidase N)/APN 和 leukotriene A4 hydrolase 抑制剂,可用于癌症研究。 | |||
T19791 |
Chamazulene
BA2784,BA 2784,BA-2784,Dimethulene |
||
Chamazulene is an anti-inflammatory agent as well as an antioxidant-type inhibitor of leukotriene B4 formation. | |||
TN5180 | Triptinin B | Others | Others |
Triptinin A and triptinin B are leukotriene D4 antagonist constituents. | |||
T62258 |
Bestatin trifluoroacetate
|
||
Bestatin trifluoroacetate (Ubenimex trifluoroacetate) 是一种 CD13 (Aminopeptidase N)/APN 和 leukotriene A4 hydrolase 抑制剂,经常用于研究癌症。 | |||
TN6057 |
1-Methyl-2-[(Z)-6-undecenyl]-4(1H)-quinolone
(Z)-1-Methyl-2-(undec-6-enyl)quinolin-4(1H)-one |
||
(Z)-1-Methyl-2-(undec-6-enyl)quinolin-4(1H)-one shows strong inhibitory activity on leukotriene biosynthesis in human polymorphonuclear granulocytes, and it is very effective against mycobacteria. | |||
TN2552 | 1-Methyl-2-nonylquinolin-4(1H)-one | Others | Others |
1-Methyl-2-nonylquinolin-4(1H)-one has anti-inflammatory activity, it exhibits inhibitory activity on leukotriene biosynthesis in a bioassay using human polymorphonuclear granulocytes, with IC50 values of 12.1 microM. | |||
TN5070 | Stilbostemin B | Others | Others |
Stilbostemin A, stilbostemin B , stilbostemin D , stilbostemin F , and stilbostemin G show structure-dependent inhibition of leukotriene biosynthesis with IC(50) values ranging from 3.7 to >50 microM. | |||
T37972 |
12-OxoETE
|
||
12-OxoETE is synthesized by human platelets and Aplysia nervous tissue after incubation with arachidonic acid. Microsomal fractions of various tissues will reduce 12-oxoETE to 12(S)-HETE or a mixture of 12(S)- and 12(R)-HETE. 12-OxoETE induces a rapid, dose dependent increase of cytoplasmic free calcium via a leukotriene B4 receptor or a common activation sequence. | |||
TN2511 |
Britannilactone diacetate
1,6-O,O-Diacetylbritannilactone |
IL Receptor; PARP; ROS; MAPK; Caspase; JAK; JNK; STAT | Angiogenesis; Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair; Immunology/Inflammation; JAK/STAT signaling; MAPK; Proteases/Proteasome; Stem Cells |
1,6-O,O-Diacetylbritannilactone(OODBL) has anti-inflammatory activity, it has a potential therapeutic efficacy on inflammatory diseases especially allergic airway disease as a lead compound. OODBL has anti-asthmatic activity, it reduces leukotriene C4 pro | |||
T36051 |
Lipoxin A4
脂氧素 A4,LXA4 |
||
Lipoxin A4 (LXA4) is a trihydroxy fatty acid containing a conjugated tetraene, produced by the metabolism of (±)15-HETE or 15-HpETE with human leukocytes.[1] LXA4 is equipotent to leukotriene B4 in inducing superoxide generation in human neutrophils at 0.1 μM.2 LXA4 is associated with several other biological functions including leukocyte activation, chemotaxis effects, natural killer cell inhibition, and monocyte migration and adhesion.[2],[3],[4] Analytical and biological comparisons of synth... | |||
TN4584 |
Morolic acid
|
IL Receptor; COX; HIV Protease | Immunology/Inflammation; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
Morolic acid and moronic acid have shown sustained antidiabetic and antihyperglycemic action possibly mediated by an insulin sensitization with consequent changes of glucose, cholesterol and triglycerides, in part mediated by inhibition of 11β-HSD 1. Moro |